PUBLISHER: Allied Market Research | PRODUCT CODE: 1641785
PUBLISHER: Allied Market Research | PRODUCT CODE: 1641785
Femoral Canal Brush Market By Usage , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
The femoral canal brush market was valued at $350.1 million in 2023, and is projected to reach $484.9 million by 2033, growing at a CAGR of 3.3% from 2024 to 2033.
A femoral canal brush is a specialized surgical tool used in orthopedic procedures, particularly during joint replacement surgeries. It is designed to clean and prepare the femoral canal-the hollow space within the femur (thigh bone)-by removing loose bone debris, fat, and other soft tissue residues. This preparation ensures proper cementing and fixation of the prosthetic components, promoting long-term stability and reducing the risk of complications like implant loosening.
The global femoral canal brush market is witnessing robust growth due to factors such as alarming rise in prevalence of joint disorders such as osteoarthritis, rheumatoid arthritis, and trauma-related joint injuries and increase in number of orthopedic surgeries worldwide. As per a 2022 study published by the World Health Organization, approximately 528 million individuals worldwide were suffering from osteoarthritis in 2019. This highlights the urgent need for surgical tools like femoral canal brushes. In addition, surge in geriatric population acts as a key driving force of the global market. This is attributed to the fact that with the global aging population growing rapidly, the demand for hip and knee replacements is on the rise. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Furthermore, rapid development of healthcare infrastructure in emerging economies, such as India, Brazil, and China, has increased access to orthopedic surgeries, supporting the growth of the femoral canal brush market. Post-operative infections remain a critical concern in orthopedic procedures. Femoral canal brushes play a key role in reducing the risk of infections by ensuring a clean surgical site, thereby further driving their demand. However, high cost of femoral canal brushes and other surgical instruments can be a barrier, particularly in emerging markets and regions with limited healthcare budgets. In addition, rise of non-invasive or minimally invasive surgical procedures, which might not require femoral canal brushes, could impact their demand, thus hampering the market growth. On the contrary, innovations in materials and design, such as biocompatible and durable bristles, have enhanced the efficiency of femoral canal brushes. This has driven their adoption in orthopedic procedures, which is expected to offer remunerative opportunities for the expansion of the global market during the forecast period.
The global femoral canal brush market size is segmented into usage, application, end user, and region. On the basis of the usage, the market is bifurcated into cleaning and debride. By application, it is classified into bone cement, hip replacement, joint replacement, and others. Depending on end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By usage, the cleaning segment is expected to dominate the market from 2024 to 2033.
On the basis of application, the bone cement segment is anticipated to exhibit the highest growth rate during the forecast period.
Depending on end user, the hospitals segment is projected to lead the femoral canal brush market in the upcoming years.
Region wise, North America is likely to emerge as the most lucrative market for femoral canal brushes throughout the forecast period.
Competition Analysis
The major players operating in the global femoral canal brush market include Stryker Corporation, B. Braun SE, Becton, Dickinson and Company , Advanced Medical Systems Limited, McKesson Medical-Surgical Inc., Judd Medical Limited , Zimmer Biomet, Smith & Nephew, Tecres S.p.A., and Edwards Lifesciences Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Usage
- Cleaning
- Debride
By Application
- Bone Cement
- Hip Replacement
- Joint Replacement
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Stryker Corporation
- B. Braun SE
- Becton, Dickinson and Company
- Advanced Medical Systems Limited
- McKesson Medical-Surgical Inc.
- Judd Medical Limited
- Zimmer Biomet
- Smith & Nephew
- Tecres S.p.A.
- Edwards Lifesciences Corporation
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: FEMORAL CANAL BRUSH MARKET, BY USAGE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Usage
- 4.2. Cleaning
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Debride
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
CHAPTER 5: FEMORAL CANAL BRUSH MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Bone Cement
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Hip Replacement
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Joint Replacement
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
CHAPTER 6: FEMORAL CANAL BRUSH MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
CHAPTER 7: FEMORAL CANAL BRUSH MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Usage
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Femoral Canal Brush Market
- 7.2.6.1. Market Size and Forecast, By Usage
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Femoral Canal Brush Market
- 7.2.7.1. Market Size and Forecast, By Usage
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Femoral Canal Brush Market
- 7.2.8.1. Market Size and Forecast, By Usage
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Usage
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Femoral Canal Brush Market
- 7.3.6.1. Market Size and Forecast, By Usage
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Femoral Canal Brush Market
- 7.3.7.1. Market Size and Forecast, By Usage
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Femoral Canal Brush Market
- 7.3.8.1. Market Size and Forecast, By Usage
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Femoral Canal Brush Market
- 7.3.9.1. Market Size and Forecast, By Usage
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Femoral Canal Brush Market
- 7.3.10.1. Market Size and Forecast, By Usage
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Femoral Canal Brush Market
- 7.3.11.1. Market Size and Forecast, By Usage
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Usage
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Femoral Canal Brush Market
- 7.4.6.1. Market Size and Forecast, By Usage
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Femoral Canal Brush Market
- 7.4.7.1. Market Size and Forecast, By Usage
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Femoral Canal Brush Market
- 7.4.8.1. Market Size and Forecast, By Usage
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Femoral Canal Brush Market
- 7.4.9.1. Market Size and Forecast, By Usage
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Femoral Canal Brush Market
- 7.4.10.1. Market Size and Forecast, By Usage
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Femoral Canal Brush Market
- 7.4.11.1. Market Size and Forecast, By Usage
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Usage
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Femoral Canal Brush Market
- 7.5.6.1. Market Size and Forecast, By Usage
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Femoral Canal Brush Market
- 7.5.7.1. Market Size and Forecast, By Usage
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Femoral Canal Brush Market
- 7.5.8.1. Market Size and Forecast, By Usage
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Femoral Canal Brush Market
- 7.5.9.1. Market Size and Forecast, By Usage
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
- 9.1. Stryker Corporation
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. B. Braun SE
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Becton, Dickinson And Company
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Advanced Medical Systems Limited
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. McKesson Medical-Surgical Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Judd Medical Limited
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Zimmer Biomet
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Smith And Nephew
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Tecres S.p.A.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Edwards Lifesciences Corporation
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
